Recent regulatory changes are reshaping the drug development landscape, with agencies such as the US Food and Drug Administration moving to phase out traditional animal testing requirements. This shift is driving the adoption of new approach methodologies, which include advanced in vitro models that better reflect human biology. In this webinar, Kevin Grady and Manisha Nautiyal will discuss strategies for building complex in vitro models that improve biological relevance, evaluate therapies more effectively, and reduce reliance on animal testing.
Topics to be covered:
- Utilizing primary human cells and media to optimize drug screening and testing
- Building biologically relevant and predictive models using co-cultured primary cells
- The benefits of 3D cell models and strategies for developing them
Tuesday, August 12th, 2025 | 11:00 AM - 12:30 PM Eastern Time
This webinar will be available to view live and on demand.
Speakers
Manisha Nautiyal, PhD
Principal Scientist
Lonza
Kevin Grady
Associate Director, Marketing Strategy
Lonza
